Vol. 2 No. 7 (2022)
Health Technology Reviews

Platform, Basket, and Umbrella Trial Designs: Stakeholder Perspectives of Novel Therapeutics

Published July 6, 2022

Key Messages

  • Advancements in genomic and precision medicine have changed the way oncology clinical trials are designed. Compared to the traditional single tumour-based trial, master protocols, which are often classified as basket, umbrella, or platform trials, conduct studies on multiple subgroups under a single overarching protocol.
  • This paper presents the perspectives of patients, clinicians, public payers, private payers, and industry, which were discussed during the third webinar.
  • The discussion section of this paper summarizes the major points raised by the presenters, as well as questions from the audience and answers from the presenters.